N. P. Jones

620 total citations
6 papers, 375 citations indexed

About

N. P. Jones is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, N. P. Jones has authored 6 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 1 paper in Epidemiology. Recurrent topics in N. P. Jones's work include Peroxisome Proliferator-Activated Receptors (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Treatment and Management (5 papers). N. P. Jones is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Treatment and Management (5 papers). N. P. Jones collaborates with scholars based in United States, Australia and Netherlands. N. P. Jones's co-authors include Rita Patwardhan, Bruce H. R. Wolffenbuttel, Ramón Gomis, Sebastiano Squatrito, John J. Nolan, Ajai Agrawal, John Wilding, Mark Heise, Mark Walker and S. M. A. Bennett and has published in prestigious journals such as Diabetic Medicine and Diabetes Research and Clinical Practice.

In The Last Decade

N. P. Jones

6 papers receiving 349 citations

Peers

Countries citing papers authored by N. P. Jones

Since Specialization

Citations

This map shows the geographic impact of N. P. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. P. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. P. Jones more than expected).

Fields of papers citing papers by N. P. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. P. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. P. Jones. The network helps show where N. P. Jones may publish in the future.

Co-authorship network of co-authors of N. P. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of N. P. Jones. A scholar is included among the top collaborators of N. P. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. P. Jones. N. P. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance 2004 ·Diabetic Medicine ·S. M. A. Bennett, Ajai Agrawal, (unknown), Mark Heise, N. P. Jones, Mark Walker, John Wilding	58
2	Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus 2000 ·Diabetic Medicine ·John J. Nolan, N. P. Jones, Rita Patwardhan, (unknown)	99
3	Rosiglitazone increases insulin sensitivity and reduces factors associated with insulin resistance in type 2 diabetics 2000 ·Diabetes Research and Clinical Practice ·(unknown), (unknown), Graham J. Galloway, (unknown), (unknown), N. P. Jones, Nandita Biswas	9
4	Addition of low‐dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients 2000 ·Diabetic Medicine ·Bruce H. R. Wolffenbuttel, Ramón Gomis, Sebastiano Squatrito, N. P. Jones, Rita Patwardhan	205
5	Proinsulin/insulin ratio reduced and β-cell function improved in type 2 diabetes with rosiglitazone 2000 ·Diabetes Research and Clinical Practice ·Steven E. Kahn, (unknown), (unknown), N. P. Jones, Nandita Biswas	1
6	Rosiglitazone: Long-term efficacy in combination with metformin or as monotherapy 2000 ·Diabetes Research and Clinical Practice ·N. P. Jones, (unknown), Stuart Owen, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact